Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm associated with the BCR-ABL1 fusion oncogenes generated upon t(9;22) chromosomal translocations in hematopoietic stem cells (HSCs)1. This evidence concerns the gene BCR and myeloproliferative neoplasm.